Who is sponsoring NCT03501004?

NCT03501004 is sponsored by Tsinghua University.

What drugs are being tested in NCT03501004?

Interventions in NCT03501004: Sterile acupuncture needles for single use.

What condition does NCT03501004 study?

NCT03501004 studies Acupuncture, Parkinson's Disease, Sleep Disorders, Neuroimaging.

Is NCT03501004 still recruiting?

NCT03501004 is currently completed. Last updated 12 April 2021.

Last reviewed 2021-04-12 · How we verify

NCT03501004

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Study of Acupuncture on Vascular and Functional Neuroimaging in Parkinson's Disease Patients With Sleep Disorders

Completed NA Last updated 12 April 2021

What this trial tests

NA trial testing Sterile acupuncture needles for single use in Acupuncture in 15 participants. Completed in 30 September 2020.

Timeline

1 June 2018

Primary endpoint
30 June 2020

30 September 2020

Quick facts

Lead sponsor	Tsinghua University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	triple
Primary purpose	treatment
Enrollment	15
Start date	1 June 2018
Primary completion	30 June 2020
Estimated completion	30 September 2020
Sites	1 location across China

Drugs / interventions tested

Sterile acupuncture needles for single use

Conditions studied

Acupuncture — all drugs for Acupuncture →
Parkinson's Disease — all drugs for Parkinson's Disease →
Sleep Disorders — all drugs for Sleep Disorders →
Neuroimaging — all drugs for Neuroimaging →

Sponsor

Tsinghua University

Who can join

Adults 40 to 70, any sex, with Acupuncture or Parkinson's Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to compare vascular and functional neurological changes of acupuncture in patients with Parkinson's Disease and Sleep Disorders. In the randomized controlled clinical trial study, patients meeting the criteria for inclusion will be randomly enrolled and divided into two groups in a 1:1 ratio: the acupuncture group and the sham acupuncture group. The intervention is going to be executed using the acupoints GV14（Dazhui）and GB20 (Fengchi).The acupuncture needles will be inserted to a depth of 0.8 to 1 cm using GV14（Dazhui）and GB20 (Fengchi) in the acupuncture group. The sham acupuncture group's needles will be inserted to a depth of 0.1 to 0.2 cm with nonacupuncture points located 0.5 cm in lateral to the real acupoint or to the right for midline points.During the study, researchers will observe changes in cerebral blood vessels and neuroimaging before and after acupuncture in the two groups. Using multimodal fusion advanced vascular-neuronal imaging techniques could evaluate the effect of acupuncture on brain blood vessels and function in patients with Parkinson's disease and Sleep Disorders and provide an objective neuroimaging basis for assessing the effectiveness of acupuncture.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

News from the Field
· 2018

Verify or expand the search:

Other recruiting trials for Acupuncture

Currently open trials in the same condition.

NCT06910540 — ACU-TENS on Pain and Stress Reduction Before and During TUGOR · NA · recruiting
NCT06725550 — Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 · NA · recruiting
NCT07036393 — Acupuncture Versus Transcutaneous Electrical Nerve Stimulation on Pain Post Upper Abdominal Surgeries · NA · recruiting
NCT07058259 — Acupuncture for Persistent Dyspnea Despite Medical Treatment in COPD · NA · active not recruiting
NCT06757023 — A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment · recruiting

Other Tsinghua University trials

Trials by the same sponsor.

NCT07171086 — AI-POCUS for Maternal and Neonatal Health in Ethiopia · Phase 4 · not yet recruiting
NCT06980467 — Evaluation of AI-Generated Clinical Advice by Physicians · NA · not yet recruiting
NCT06962423 — AI-driven Automated Biomedical Research · NA · not yet recruiting
NCT06923410 — Clinical Intelligent Management System - Multilingual Exploration · NA · recruiting
NCT06893068 — Clinical Intelligent Management System Pragmatic RCT · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03501004 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tsinghua University
Last refreshed: 12 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03501004.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing